Evidence map›Paper›PMID 10751345›Full record

ArticleThe American journal of pathology2000

Rapid shift from virally infected cells to germinal center-retained virus after HIV-2 infection of macaques.

F Eitner, Y Cui, G Grouard-Vogel, K L Hudkins, A Schmidt, T Birkebak, M B Agy, S L Hu, W R Morton, D M Anderson and 2 more

Open access · greenAbstract read
In one paragraph

Article in The American journal of pathology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

F EitnerDepartment of Pathology, University of Washington, Seattle, Washington 98195, USA.
Y Cui
G Grouard-Vogel
K L Hudkins
A Schmidt
T Birkebak
M B Agy
S L Hu
W R Morton
D M Anderson
E A Clark
C E Alpers
University of Washington · US

Funding

YILMA SIV VACCINIA VACCINE TRIALP51RR000166 · NCRR · UNIVERSITY OF WASHINGTON · PI HU, SHIU-LOK · 1985 to 2011
$161.1M
ROLE OF THE TUBULOINTERSTITIUM IN SALT-DEPENDENT HYPERTENSIONP50DK047659 · NIDDK · UNIVERSITY OF WASHINGTON · PI ALPERS, CHARLES · 1993 to 2002
$2.2M
PATHOGENESIS OF HIV ASSOC THROMBOTIC MICROANGIOPATHYR01HL063652 · NHLBI · UNIVERSITY OF WASHINGTON · PI ALPERS, CHARLES E · 1999 to 2003
$1.1M
DEVELOPMENT OF PRIMATE MODELS OF HIV RELATED NEPHROPATHYR01DK049514 · NIDDK · UNIVERSITY OF WASHINGTON · PI ALPERS, CHARLES E · 1994 to 1997
–
NCRR NIH HHS P51 RR000166NHLBI NIH HHS HL 63652NHLBI NIH HHS R01 HL063652NIDDK NIH HHS DK 47659NIDDK NIH HHS DK 49514
6 · The paper itself

Abstract

Lymphoid tissues are the primary target during the initial virus dissemination that occurs in HIV-1-infected individuals. Recent advances in antiretroviral therapy and techniques to monitor virus load in humans have demonstrated that the early stages of viral infection and host response are major determinants of the outcome of individual infections. Relatively little is known about immunopathogenic events occurring during the acute phase of HIV infection. We analyzed viral dissemination within lymphoid tissues by in situ hybridization and by combined immunohistochemistry/in situ hybridization during the acute infection phase (12 hours to 28 days) in pig-tailed macaques (Macaca nemestrina), challenged intravenously with a virulent strain of HIV-2, HIV-2(287). Two stages in viral dissemination were clearly evident within the first 28 days after HIV-2(287) infection. First, a massive increase in individual HIV-2-infected cells, mostly CD3+ T lymphocytes and a smaller percentage of macrophages and interdigitating dendritic cells, was identified within lymph nodes which peaked on the 10th day after HIV-2 infection. A shift of HIV-2 distribution was demonstrable between day 10 and day 14 after HIV-2 infection. Coincident with a marked reduction in individual HIV-2 RNA+ cells by day 14 postinfection, there was a dramatic increase in germinal center-associated HIV-2 RNA. High concentrations of HIV-2 RNA persisted in germinal centers in all animals by days 21 and 28 postinfection. Thus, HIV-2 appears to go through an initial, highly disseminated cellular phase followed by localization in the follicular dendritic cell network with relatively few infected cells. In this nonhuman primate model of HIV-associated immunopathogenesis, using a virus derived from a human pathogen, we identified a significant shift in the pattern of HIV-2 localization within a narrow time frame (day 10 to day 14). This shift in virus localization and behavior indicates that there may be a discrete but remarkably narrow window for therapeutic interventions that interrupt this stage in the natural course of HIV infection. Reproducibility and the accelerated time course of disease development make this model an excellent candidate for such intervention studies.

Indexed as

AnimalsAntibodies, ViralDendritic CellsFemaleGerminal CenterHIV-2HIV InfectionsLymph NodesMacaca nemestrinaMaleMesenteryRNA, ViralTime FactorsT-LymphocytesAntibodies, ViralRNA, Viral

Identifiers

PMID10751345
PMCPMC1876883
OpenAlexW2124287679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.